Bioteque Corporation (TPEX: 4107)

Market Cap	8.28B
Revenue (ttm)	2.09B
Net Income (ttm)	499.22M
Shares Out	69.30M
EPS (ttm)	7.17
PE Ratio	16.67
Forward PE	15.89
Dividend	4.50 (3.77%)
Ex-Dividend Date	Jul 30, 2024

Volume	121,774
Open	121.00
Previous Close	121.50
Day's Range	120.00 - 121.50
52-Week Range	106.50 - 147.50
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2023, Bioteque's revenue was 1.94 billion, a decrease of -3.26% compared to the previous year's 2.01 billion. Earnings were 452.55 million, a decrease of -8.31%.